Stuart C. Ray
- Virology top 0.1%
- HIV Research and Treatment 58
- Hepatology top 0.05%
- Hepatitis C virus research 71
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment 33
- HIV/AIDS Research and Interventions 18
- Parasitology top 0.2%
- Epidemiology top 0.2%
- Hepatitis B Virus Studies 46
- Liver Disease Diagnosis and Treatment 18
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Immune Cell Function and Interaction 15
- Co-authors
- David L. ThomasAndrea L. CoxDouglas R. CavenerRobert C. BollingerRoxann IngersollHaynes W. SheppardSmita KulkarniKavita S. Lole
- Journals
- Journal of Virology (24 papers)The Journal of Infectious Diseases (11 papers)Clinical Infectious Diseases (7 papers)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Stuart C. Ray
146 papers receiving 13.4k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Virology 3.8k
- Hepatology 5.6k
- Infectious Diseases 5.1k
- Parasitology 1.5k
- Epidemiology 5.5k
Countries citing papers authored by Stuart C. Ray
This map shows the geographic impact of Stuart C. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Ray more than expected).
Fields of papers citing papers by Stuart C. Ray
This network shows the impact of papers produced by Stuart C. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Ray. The network helps show where Stuart C. Ray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart C. Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 57 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 36 | |
| 14 | 2018 | 0 | |
| 15 | 2018 | 50 | |
| 16 | The effect of Maraviroc intensification on gut reservoir and immune function in HIV-1-infected individuals receiving antiretroviral therapy with suboptimal CD4+T cell recovery | 2016 | 1 |
| 17 | 2015 | 17 | |
| 18 | 2011 | 6 | |
| 19 | Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFbreakdown → | 2005 | 846 |
| 20 | 1994 | 31 |
About Stuart C. Ray
Stuart C. Ray is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 152 papers that have together received 13.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (71 papers), HIV Research and Treatment (58 papers), Hepatitis B Virus Studies (46 papers), HIV/AIDS drug development and treatment (33 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Liver Disease Diagnosis and Treatment (18 papers), HIV/AIDS Research and Interventions (18 papers) and Immune Cell Function and Interaction (15 papers). The work is most often cited by research in Virology (3.8k citations), Hepatology (5.6k citations) and Infectious Diseases (5.1k citations). Stuart C. Ray has collaborated with scholars based in United States, China and India. Frequent co-authors include David L. Thomas, Andrea L. Cox, Douglas R. Cavener, Robert C. Bollinger, Roxann Ingersoll, Haynes W. Sheppard, Smita Kulkarni, Kavita S. Lole, Nicole G. Novak and Ramesh Paranjape. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases, Clinical Infectious Diseases, Hepatology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.